nach oben

Erschienen in:

27.01.2022 | Review

Gastroesophageal Cancer After Gastric Bypass Surgeries: a Systematic Review and Meta-analysis

verfasst von: Rodrigue Chemaly, Samer Diab, Georges Khazen, Georges Al-Hajj

Erschienen in: Obesity Surgery | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Data comparing the occurrence of gastroesophageal cancer after gastric bypass procedures are lacking and are only available in the form of case reports. We perform in this study a systematic review and a meta-analysis of all the reported cases of gastroesophageal cancer following Roux-en-Y gastric bypass (RYGB) and loop gastric bypass-one anastomosis gastric bypass/mini gastric bypass (LGB-OAGB/MGB). We conducted a systematic review of all the reported cases in articles referenced in PubMed/Medline, Cochrane, and Scholar Google. Only cases of gastro-esophageal adenocarcinoma following RYGB or LGB-OAGB/MGB are included. Statistical analysis was done accordingly. Fifty cases were identified, along with 2 reported in this paper. Sixty-one percent (27/44) of the cancers after RYGB were in the gastric tube compared to 37.5% (3/8) after LGB-OAGB/MGB. This resulted in an odds ratio of 0.38 (p-value = 0.26), which failed to prove an increase in cancer occurrence in the gastric tube after LGB-MGB/OAGB compared to RYGB. The most common symptoms were dysphagia for cancers occurring in the gastric tube (15/30) and abdominal pain for those occurring in the excluded stomach (10/22). Twenty-nine/thirty of the cancers in the gastric tube were diagnosed by gastroscopy and 13/22 of the cancers in the excluded stomach were diagnosed by CT scan. Gastroesophageal cancers after gastric bypass procedures occur commonly in the excluded stomach where many are not identified by conventional means. Physician awareness and patient education as well as lifelong follow-up are essential for maintaining bypass surgeries on the beneficial side.

Nur mit Berechtigung zugänglich

Organization WH. Overweight and Obesity [Internet]. 2017. Available from: https://www.who.int/gho/ncd/risk_factors/overweight_obesity/obesity_adults/en/.

Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78. https://doi.org/10.1016/S0140-6736(08)60269-X.CrossRefPubMed

Adams TD, Hunt SC. Cancer and obesity: effect of bariatric surgery. World J Surg. 2009;33(10):2028–33. https://doi.org/10.1007/s00268-009-0169-1.CrossRefPubMed

Upala S, Sanguankeo A. Bariatric surgery reduces risk of endometrial cancer. Surg Obes Relat Dis. 2015;11(6):1410. https://doi.org/10.1016/j.soard.2015.08.501.CrossRefPubMed

Afshar S, Kelly SB, Seymour K, Lara J, Woodcock S, Mathers JC. The effects of bariatric surgery on colorectal cancer risk: systematic review and meta-analysis. Obes Surg. 2014;24(10):1793–9. https://doi.org/10.1007/s11695-014-1359-y.CrossRefPubMed

Tee MC, Cao Y, Warnock GL, Hu FB, Chavarro JE. Effect of bariatric surgery on oncologic outcomes: a systematic review and meta-analysis. Surg Endosc. 2013;27(12):4449–56. https://doi.org/10.1007/s00464-013-3127-9.CrossRefPubMedPubMedCentral

Casagrande DS, Rosa DD, Umpierre D, Sarmento RA, Rodrigues CG, Schaan BD. Incidence of cancer following bariatric surgery: systematic review and meta-analysis. Obes Surg. 2014;24(9):1499–509. https://doi.org/10.1007/s11695-014-1276-0.CrossRefPubMed

Borbély Y, Schaffner E, Zimmermann L, Huguenin M, Plitzko G, Nett P, Kröll D. De novo gastroesophageal reflux disease after sleeve gastrectomy: role of preoperative silent reflux. Surg Endosc. 2019;33(3):789–93. https://doi.org/10.1007/s00464-018-6344-4.CrossRefPubMed

Qumseya BJ, Qumsiyeh Y, Ponniah SA, Estores D, Yang D, Johnson-Mann CN, Friedman J, Ayzengart A, Draganov PV. Barrett’s esophagus after sleeve gastrectomy: a systematic review and meta-analysis. Gastrointest Endosc. 2021;93(2):343-352.e2. https://doi.org/10.1016/j.gie.2020.08.008.CrossRefPubMed

10.

Scozzari G, Trapani R, Toppino M, Morino M. Esophagogastric cancer after bariatric surgery: systematic review of the literature. Surg Obes Relat Dis. 2013;9(1):133–42. https://doi.org/10.1016/j.soard.2012.10.002.CrossRefPubMed

11.

Orlando G, Pilone V, Vitiello A, Gervasi R, Lerose MA, Silecchia G, Puzziello A. Gastric cancer following bariatric surgery: a review. Surg Laparosc Endosc Percutan Tech. 2014;24(5):400–5. https://doi.org/10.1097/SLE.0000000000000050.CrossRefPubMed

12.

Team RC. R: a language and environment for statistical computing [Internet]. R Foundation for Statistical Computing, Vienna, Austria. 2017. Available from: https://www.r-project.org/.

13.

Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37. https://doi.org/10.1001/jama.292.14.1724.CrossRefPubMed

14.

Poirier P, Cornier MA, Mazzone T, Stiles S, Cummings S, Klein S, McCullough PA, Ren Fielding C, Franklin BA, American Heart Association Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation. 2011;123(15):1683–701. https://doi.org/10.1161/CIR.0b013e3182149099.CrossRefPubMed

15.

Rutledge R, Walsh TR. Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg. 2005;15(9):1304–8. https://doi.org/10.1381/096089205774512663.CrossRefPubMed

16.

García-Caballero M, Carbajo M. One anastomosis gastric bypass: a simple, safe and efficient surgical procedure for treating morbid obesity. Nutr Hosp. 2004;19(6):372–5.PubMed

17.

Takeno S, Hashimoto T, Maki K, Shibata R, Shiwaku H, Yamana I, Yamashita R, Yamashita Y. Gastric cancer arising from the remnant stomach after distal gastrectomy: a review. World J Gastroenterol. 2014;20(38):13734–40. https://doi.org/10.3748/wjg.v20.i38.13734.CrossRefPubMedPubMedCentral

18.

Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11(3):276–80. https://doi.org/10.1381/096089201321336584.CrossRefPubMed

19.

Noun R, Skaff J, Riachi E, Daher R, Antoun NA, Nasr M. One thousand consecutive mini-gastric bypass: short- and long-term outcome. Obes Surg. 2012;22(5):697–703. https://doi.org/10.1007/s11695-012-0618-z.CrossRefPubMed

20.

Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, Roux-En-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. 2016;26(5):926–32. https://doi.org/10.1007/s11695-015-1869-2.CrossRefPubMed

21.

Tolone S, Cristiano S, Savarino E, Lucido FS, Fico DI, Docimo L. Effects of omega-loop bypass on esophagogastric junction function. Surg Obes Relat Dis. 2016;12(1):62–9. https://doi.org/10.1016/j.soard.2015.03.011.CrossRefPubMed

22.

Doulami G, Triantafyllou S, Albanopoulos K, Natoudi M, Zografos G, Theodorou D. Acid and nonacid gastroesophageal reflux after single anastomosis gastric bypass. An objective assessment using 24-hour multichannel intraluminal impedance-pH metry. Surg Obes Relat Dis. 2018;14(4):484–8. https://doi.org/10.1016/j.soard.2017.10.012.CrossRefPubMed

23.

Keleidari B, Mahmoudieh M, DavarpanahJazi AH, Melali H, Nasr Esfahani F, Minakari M, Mokhtari M. Comparison of the bile reflux frequency in one anastomosis gastric bypass and Roux-en-Y gastric bypass: a cohort study. Obes Surg. 2019;29(6):1721–5. https://doi.org/10.1007/s11695-018-03683-6.CrossRefPubMed

24.

Saarinen T, Räsänen J, Salo J, Loimaala A, Pitkonen M, Leivonen M, Juuti A. Bile reflux scintigraphy after mini-gastric bypass. Obes Surg. 2017;27(8):2083–9. https://doi.org/10.1007/s11695-017-2608-7.CrossRefPubMed

25.

Bruzzi M, Duboc H, Gronnier C, Rainteau D, Couvelard A, Le Gall M, Bado A, Chevallier JM. Long-term evaluation of biliary reflux after experimental one-anastomosis gastric bypass in rats. Obes Surg. 2017;27(4):1119–22. https://doi.org/10.1007/s11695-017-2577-x.CrossRefPubMed

26.

Siebert M, Ribeiro-Parenti L, Nguyen ND, Hourseau M, Duchêne B, Humbert L, Jonckheere N, Nuel G, Chevallier JM, Duboc H, Rainteau D, Msika S, Kapel N, Couvelard A, Bado A, Le Gall M. Long-term consequences of one anastomosis gastric bypass on esogastric mucosa in a preclinical rat model. Sci Rep. 2020;10(1):7393. https://doi.org/10.1038/s41598-020-64425-2.CrossRefPubMedPubMedCentral

27.

Donohoe CL, O’Farrell NJ, Doyle SL, Reynolds JV. The role of obesity in gastrointestinal cancer: evidence and opinion. Therap Adv Gastroenterol. 2014;7(1):38–50. https://doi.org/10.1177/1756283X13501786.CrossRefPubMedPubMedCentral

28.

Pallati PK, Shaligram A, Shostrom VK, Oleynikov D, McBride CL, Goede MR. Improvement in gastroesophageal reflux disease symptoms after various bariatric procedures: review of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2014;10(3):502–7. https://doi.org/10.1016/j.soard.2013.07.018.CrossRefPubMed

29.

Varban OA, Hawasli AA, Carlin AM, Genaw JA, English W, Dimick JB, Wood MH, Birkmeyer JD, Birkmeyer NJ, Finks JF. Variation in utilization of acid-reducing medication at 1 year following bariatric surgery: results from the Michigan Bariatric Surgery Collaborative. Surg Obes Relat Dis. 2015;11(1):222–8. https://doi.org/10.1016/j.soard.2014.04.027.CrossRefPubMed

30.

Suter M. Gastroesophageal reflux disease, obesity, and Roux-en-Y gastric bypass: complex relationship-a narrative review. Obes Surg. 2020;30(8):3178–87. https://doi.org/10.1007/s11695-020-04690-2.CrossRefPubMed

31.

Sundbom M, Hedenström H, Gustavsson S. Duodenogastric bile reflux after gastric bypass: a cholescintigraphic study. Dig Dis Sci. 2002;47(8):1891–6. https://doi.org/10.1023/a:1016429603337.CrossRefPubMed

32.

Ravacci GR, Ishida R, Torrinhas RS, Sala P, Machado NM, Fonseca DC, André Baptista Canuto G, Pinto E, Nascimento V, Franco Maggi Tavares M, Sakai P, Faintuch J, Santo MA, Moura EGH, Neto RA, Logullo AF, Waitzberg DL. Potential premalignant status of gastric portion excluded after Roux en-Y gastric bypass in obese women: a pilot study. Sci Rep. 2019;9(1):5582. https://doi.org/10.1038/s41598-019-42082-4.

33.

Ahmad BN, Ahmad WN, Aalam WK, Ahmad SM, Hussain KS. Duodenogastric reflux, an important cause of post cholecystectomy symptoms. JK Pract. 2003;10(3):188–90.

34.

Kumar N, Thompson CC. Remnant gastropathy due to bile reflux after Roux-en-Y gastric bypass: a unique cause of abdominal pain and successful treatment with ursodiol. Surg Endosc. 2017;31(12):5399–402. https://doi.org/10.1007/s00464-017-5621-y.CrossRefPubMedPubMedCentral

35.

Csendes A, Burdiles P, Papapietro K, Diaz JC, Maluenda F, Burgos A, Rojas J. Results of gastric bypass plus resection of the distal excluded gastric segment in patients with morbid obesity. J Gastrointest Surg. 2005;9(1):121–31. https://doi.org/10.1016/j.gassur.2004.05.006.CrossRefPubMed

36.

Vella E, Hovorka Z, Yarbrough DE, McQuitty E. Bile reflux of the remnant stomach following Roux-en-Y gastric bypass: an etiology of chronic abdominal pain treated with remnant gastrectomy. Surg Obes Relat Dis. 2017;13(8):1278–83. https://doi.org/10.1016/j.soard.2017.04.007.CrossRefPubMed

37.

Raijman I, Strother SV, Donegan WL. Gastric cancer after gastric bypass for obesity. Case report J Clin Gastroenterol. 1991;13(2):191–4. https://doi.org/10.1097/00004836-199104000-00015.CrossRefPubMed

38.

Lord RV, Edwards PD, Coleman MJ. Gastric cancer in the bypassed segment after operation for morbid obesity. Aust N Z J Surg. 1997;67(8):580–2. https://doi.org/10.1111/j.1445-2197.1997.tb02047.x.CrossRefPubMed

39.

Khitin L, Roses RE, Birkett DH. Cancer in the gastric remnant after gastric bypass: a case report. Curr Surg. 2003;60(5):521–3. https://doi.org/10.1016/S0149-7944(03)00052-7.CrossRefPubMed

40.

Babor R, Booth M. Adenocarcinoma of the gastric pouch 26 years after loop gastric bypass. Obes Surg. 2006;16(7):935–8. https://doi.org/10.1381/096089206777822223.CrossRefPubMed

41.

Swain JM, Adams RB, Farnell MB, Que FG, Sarr MG. Gastric and pancreatoduodenal resection for malignant lesions after previous gastric bypass–diagnosis and methods of reconstruction. Surg Obes Relat Dis. 2010;6(6):670–5. https://doi.org/10.1016/j.soard.2010.03.287.CrossRefPubMed

42.

Wu CC, Lee WJ, Ser KH, Chen JC, Tsou JJ, Chen SC, Kuan WS. Gastric cancer after mini-gastric bypass surgery: a case report and literature review. Asian J Endosc Surg. 2013;6(4):303–6. https://doi.org/10.1111/ases.12052.CrossRefPubMed

43.

Allen JW, Leeman MF, Richardson JD. Esophageal carcinoma following bariatric procedures. JSLS. 2004;8(4):372–5.PubMedPubMedCentral

44.

Escalona A, Guzmán S, Ibáñez L, Meneses L, Huete A, Solar A. Gastric cancer after Roux-en-Y gastric bypass. Obes Surg. 2005;15(3):423–7. https://doi.org/10.1381/0960892053576668.CrossRefPubMed

45.

Trincado MT, del Olmo JC, GarcíaCastaño J, Cuesta C, Blanco JI, Awad S, Carbajo MA. Gastric pouch carcinoma after gastric bypass for morbid obesity. Obes Surg. 2005;15(8):1215–7. https://doi.org/10.1381/0960892055002383.CrossRefPubMed

46.

Nguyen NT, Tran CL, Gelfand DV, Varela E, Chang K, Stamos M, Wilson SE. Laparoscopic and thoracoscopic Ivor Lewis esophagectomy after Roux-en-Y gastric bypass. Ann Thorac Surg. 2006;82(5):1910–3. https://doi.org/10.1016/j.athoracsur.2006.02.065.CrossRefPubMed

47.

Corsini DA, Simoneti CA, Moreira G, Lima SE Jr, Garrido AB. Cancer in the excluded stomach 4 years after gastric bypass. Obes Surg. 2006;16(7):932–4. https://doi.org/10.1381/096089206777822313.CrossRefPubMed

48.

Harper JL, Beech D, Tichansky DS, Madan AK. Cancer in the bypassed stomach presenting early after gastric bypass. Obes Surg. 2007;17(9):1268–71. https://doi.org/10.1007/s11695-007-9216-x.CrossRefPubMed

49.

Watkins BJ, Blackmun S, Kuehner ME. Gastric adenocarcinoma after Roux-en-Y gastric bypass: access and evaluation of excluded stomach. Surg Obes Relat Dis. 2007;3(6):644–7. https://doi.org/10.1016/j.soard.2007.06.008.CrossRefPubMed

50.

Melstrom LG, Bentrem DJ, Salvino MJ, Blum MG, Talamonti MS, Printen KJ. Adenocarcinoma of the gastroesophageal junction after bariatric surgery. Am J Surg. 2008;196(1):135–8. https://doi.org/10.1016/j.amjsurg.2007.07.026.CrossRefPubMed

51.

Sun C, Jackson CS, Reeves M, Rendon S. Metastatic adenocarcinoma of the gastric pouch 5 years after Roux-en-Y gastric bypass. Obes Surg. 2008;18(3):345–8. https://doi.org/10.1007/s11695-007-9394-6.CrossRefPubMed

52.

Kuruba R, Jawad M, Karl RC, Murr MM. Technique of resection of esophageal adenocarcinoma after Roux-en-Y gastric bypass and literature review of esophagogastric tumors after bariatric procedures. Surg Obes Relat Dis. 2009;5(5):576–81. https://doi.org/10.1016/j.soard.2009.02.009.CrossRefPubMed

53.

Ribeiro MC, Lopes LR, de Souza Coelho Neto J, Tercioti V Jr, Andreollo NA. Gastric adenocarcinoma after gastric bypass for morbid obesity: a case report and review of the literature. Case Rep Med. 2013;2013:609727. https://doi.org/10.1155/2013/609727.CrossRefPubMedPubMedCentral

54.

Menéndez P, Villarejo P, Padilla D. Krukenberg tumor after gastric bypass for morbid obesity. Bariatric surgery and gastric cancer. Rev Esp Enferm Dig. 2013;105(5):296–8. https://doi.org/10.4321/s1130-01082013000500009.CrossRefPubMed

55.

Kulaylat AN, Sahajwani S, Staveley-O’Carroll KF, Kaifi JT. Reconstructive options for gastroesophageal junction adenocarcinoma after Roux-en-Y gastric bypass. J Thorac Cardiovasc Surg. 2013;146(5):1296–8. https://doi.org/10.1016/j.jtcvs.2013.07.007.CrossRefPubMed

56.

Rossidis G, Browning R, Hochwald SN, Abbas H, Kim T, Ben-David K. Minimally invasive esophagectomy is safe in patients with previous gastric bypass. Surg Obes Relat Dis. 2014;10(1):95–100. https://doi.org/10.1016/j.soard.2013.03.015.CrossRefPubMed

57.

Nau P, Rattner DW, Meireles O. Linitis plastica presenting two years after elective Roux-en-Y gastric bypass for treatment of morbid obesity: a case report and review of the literature. Surg Obes Relat Dis. 2014;10(2):e15-7. https://doi.org/10.1016/j.soard.2013.06.015.CrossRefPubMed

58.

Magge D, Holtzman MP. Gastric Adenocarcinoma in patients with Roux-en-Y Gastric bypass: a case series. Surg Obes Relat Dis. 2015;11(5):e35-8. https://doi.org/10.1016/j.soard.2015.05.005.CrossRefPubMed

59.

Tinoco A, Gottardi LF, Boechat ED. gastric cancer in the excluded stomach 10 years after gastric bypass. Case Rep Surg. 2015;2015:468293. https://doi.org/10.1155/2015/468293.CrossRefPubMedPubMedCentral

60.

Maret-Ouda J, Tao W, Mattsson F, Brusselaers N, El-Serag HB, Lagergren J. Esophageal adenocarcinoma after obesity surgery in a population-based cohort study. Surg Obes Relat Dis. 2017;13(1):28–34. https://doi.org/10.1016/j.soard.2015.09.016.CrossRefPubMed

61.

McFarland S, Manivel CJ, Ramaswamy A, Mesa H. Gastric-type extremely well-differentiated adenocarcinoma arising in the blind pouch of a bypassed stomach, presenting as colonic pseudo-obstruction. Ann Gastroenterol. 2015;28(4):499–501.PubMedPubMedCentral

62.

Fleetwood VA, Petersen L, Millikan KW. Gastric adenocarcinoma presenting after revisional Roux-en-Y gastric bypass. Am Surg. 2016;82(8):e186–7.CrossRefPubMed

63.

Midani D, Ehrlich AC, Kothari TH, Heller SJ. Gastric adenocarcinoma in an excluded stomach diagnosed by double balloon enteroscopy. Austin J Med Oncol. 2015;2:2–4.

64.

Keren D, Madi H, Matter I, Assalia A, Rainis T. Feasibility and importance of enteroscopy after gastric bypass. Obes Surg. 2017;27(5):1309–15. https://doi.org/10.1007/s11695-016-2472-x.CrossRefPubMed

65.

van de Vrande S, Himpens J, Leman G. Adenocarcinoma of the gastric pouch after Roux-en-Y gastric bypass: a new technique for en bloc resection and reconstruction. Surg Obes Relat Dis. 2017;13(10):1793–5. https://doi.org/10.1016/j.soard.2017.07.006.CrossRefPubMed

66.

Runkel M, Runkel N. Esophago-gastric cancer after one anastomosis gastric bypass (OAGB). Chirurgia (Bucur). 2019;114(6):686–92. https://doi.org/10.21614/chirurgia.114.6.686.CrossRef

67.

Ruyssers M, Jawad R, Gys B, Gys T, Lafullarde T. Ivor Lewis oesophagectomy for a distal adenocarcinoma of the oesophagus 10 years after Roux-en-Y Gastric bypass (RYGB). Obes Surg. 2019;29(8):2713–4. https://doi.org/10.1007/s11695-019-03938-w.CrossRefPubMed

68.

Aggarwal S, Bhambri A, Singla V, Dash NR, Sharma A. Adenocarcinoma of oesophagus involving gastro-oesophageal junction following mini-gastric bypass/one anastomosis gastric bypass. J Minim Access Surg. 2019;16(2):175–8. https://doi.org/10.4103/jmas.JMAS_320_18.CrossRef

69.

Pastorello RG, de Macedo MP, da Costa Junior WL, Begnami MDFS. Gastric pouch mixed adenoneuroendocrine carcinoma with a mixed adenocarcinoma component after Roux-en-Y Gastric bypass. J Investig Med High Impact Case Rep. 2017;5(4):2324709617740908. https://doi.org/10.1177/2324709617740908.CrossRefPubMedPubMedCentral

70.

Ali S, Chaar A, Frandah W, Altoos R, Sattar Z, Hasan M. Exploring the excluded stomach: a case series of novel endoscopic techniques to diagnose gastric cancer in the excluded stomach after Roux-en-Y gastric bypass surgery. Cureus. 2018;10(6):e2825. https://doi.org/10.7759/cureus.2825.CrossRefPubMedPubMedCentral

71.

D’Antonio A, Borgheresi P, Addesso M. An unexpected adverse event of gastric bypass: giant hyperplastic polyp showing an intramucosal adenocarcinoma. Gastrointest Endosc. 2017;86(4):734–6. https://doi.org/10.1016/j.gie.2017.03.1537.CrossRefPubMed

72.

Haenen FW, Gys B, Moreels T, Michielsen M, Gys T, Lafullarde T. Linitis plastica of the bypassed stomach 7 years after Roux-en-Y gastric bypass: a case report. Acta Chir Belg. 2017;117(6):391–3. https://doi.org/10.1080/00015458.2016.1192839.CrossRefPubMed

73.

Ahmad W, Rubin J, Kwong W. Percutaneous endoscopy to diagnose malignancy in gastric outlet obstruction of excluded stomach after gastric bypass. Ann Gastroenterol. 2017;30(3):367–9. https://doi.org/10.20524/aog.2017.0132.CrossRefPubMedPubMedCentral

74.

Chen W, Zhang G, Dong Z, Liu L, Wang Y, Chen X, Zhang J, Wang C. Cardia gastric cancer in the gastric pouch 5 years after gastric bypass: a case report. Obes Surg. 2020;30(5):2021–5. https://doi.org/10.1007/s11695-019-04336-y.CrossRefPubMed

Titel: Gastroesophageal Cancer After Gastric Bypass Surgeries: a Systematic Review and Meta-analysis
verfasst von: Rodrigue Chemaly
Samer Diab
Georges Khazen
Georges Al-Hajj
Publikationsdatum: 27.01.2022
Verlag: Springer US
Erschienen in: Obesity Surgery / Ausgabe 4/2022
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-022-05921-4

Chylous Ascites Following Gastric Bypass; Lesser-Known and Unusual Complication

Letter to the Editor

Is Overweight Related to the Prognosis of Octogenarians with Lung Cancer?

Original Contributions

Response to: Esophageal Cancer After Bariatric Surgery: Increasing Prevalence and Treatment Strategies

Letter to Editor/LED Reply

Characterization and Risk Factors for Early Biliary Complications Following Elective Bariatric Surgery: an Mbsaqip Analysis

Original Contributions

COVID-19 Vaccination and Bariatric Surgery

Zur Zeit gratis
COVID-19
Letter to the Editor

Laparoscopic Small Bowel Length Measurement in Bariatric Surgery Using a Hand-Over-Hand Technique with Marked Graspers: an Ex Vivo Experiment

Open Access
Original Contributions

Neu im Fachgebiet Chirurgie

US-Team empfiehlt Gastropexie nach Hiatushernien-Op.

14.01.2025
Zwerchfellhernie
Nachrichten

Zur Vermeidung von Rezidiven nach Reparatur einer paraösophagealen Hiatushernie sollte einem US-Team zufolge der Magen bei der Op. routinemäßig an der Bauchwand fixiert werden. Das Ergebnis einer randomisierten Studie scheint dafür zu sprechen.

Mit Lidocain kommt der Darm nicht schneller in Schwung

13.01.2025
Kolektomie
Nachrichten

Verzögertes Wiederanspringen der Darmfunktion ist ein Hauptfaktor dafür, wenn Patientinnen und Patienten nach einer Kolonresektion länger als geplant im Krankenhaus bleiben müssen. Ob man diesem Problem mit Lidocain vorbeugen kann, war Thema einer Studie.

Kein Unterschied bei inadäquaten Schocks zwischen ICD-Typen

24.12.2024
Implantierbarer Kardioverter-Defibrillator
Nachrichten

Inadäquate Schockabgaben sind ein unerwünschter Effekt der Therapie mit implantierbaren Kardioverter-Defibrillatoren. Subkutanen Geräten haftet dabei der Ruf an, dafür besonders anfällig zu sein. Die PRAETORIAN-Forschungsgruppe ist dem nachgegangen.

DCIS: Ist ein Verzicht auf eine Operation möglich?

Mammakarzinom
Nachrichten

Die COMET-Studie zeigt, dass aktives Monitoring bei Patientinnen mit duktalem Carcinoma in situ (DCIS) hinsichtlich der kumulativen Zwei-Jahres-Rate an ipsilateralen invasiven Karzinomen der leitliniengerechten Standardbehandlung nicht unterlegen ist. Dennoch wird von einem Verzicht auf eine Operation abgeraten, wie in einem begleitenden Editorial betont wird.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Gastroesophageal Cancer After Gastric Bypass Surgeries: a Systematic Review and Meta-analysis

Abstract

Weitere Artikel der Ausgabe 4/2022

Chylous Ascites Following Gastric Bypass; Lesser-Known and Unusual Complication

Is Overweight Related to the Prognosis of Octogenarians with Lung Cancer?

Response to: Esophageal Cancer After Bariatric Surgery: Increasing Prevalence and Treatment Strategies

Characterization and Risk Factors for Early Biliary Complications Following Elective Bariatric Surgery: an Mbsaqip Analysis

COVID-19 Vaccination and Bariatric Surgery

Laparoscopic Small Bowel Length Measurement in Bariatric Surgery Using a Hand-Over-Hand Technique with Marked Graspers: an Ex Vivo Experiment

Neu im Fachgebiet Chirurgie

US-Team empfiehlt Gastropexie nach Hiatushernien-Op.

Mit Lidocain kommt der Darm nicht schneller in Schwung

Kein Unterschied bei inadäquaten Schocks zwischen ICD-Typen

DCIS: Ist ein Verzicht auf eine Operation möglich?

Update Chirurgie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten